Fresenius Medical to sell $900M in notes offering

Fri, 01/21/2011 - 8:41am
Mass High Tech: The Journal of New England Technology

Fresenius Medical Care AG & Co. KGaA, a German dialysis products provider that has its U.S. headquarters in Waltham, is planning a notes offering of $500 million in senior unsecured notes due 2021 and approximately $405 million of senior unsecured notes due 2021, issued by wholly owned subsidiaries Fresenius Medical Care US Finance Inc. and FMC Finance VII S.A., respectively. The company plans to use the financing to re-pay debts and make acquisitions, including its recent buy of International Dialysis Centers from Euromedic International for about $650 million.

The notes sales are being offered to “qualified institutional buyers.” The company said in a press release today that it is not planning a public offering of the senior notes.




Share this Story

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.